dc.description.abstract |
Background: Blood transfusion is a therapeutic admistration of blood or its therapeutic
components , to be used only if no other reasonable means of replacing low blood and blood
components are available.In a current medical practice in different corners of a world, whole
blood is rarely given under emergency. In our context however; whole blood is the only
component under all circumstances due to negligence and adherences to an older protocol both
by the physician and the regional blood bank. However, in modern transfusion practices, donated
blood should be fractionated into separate therapeutic components. Some of which, includes
plasma, albumin, and clotting factor VIII can be frozen or lyophilized and kept for a very long
time or even indefinitely. Others, like platelets, must be used within few days of preparation. The
most commonly transfused component is the packed red cell, followed by platelet concentrate,
plasma, immunoglobulins, and clotting factor VIII, whereas,white blood cells are rarely
transfused. Blood component therapy also allows the judicious use of this scarce human resource
and it starts right from assessing the need of transfusion, using the appropriate components,
avoiding unnecessary transfusions, to reprimanding single unit blood transfusion. Expectedly, a
wide gap exists between blood donation and utilization; hence in the interest of our community
the right patient should get the right component at the right time.
Objective: To assess the usage of blood and its therapeutic components according to the clinical
indication and reduce in appropriate usage.
Method: Cross sectional study was conducted on a 425 blood transfusion episodes
consecutively from February to June 2018. Socio-demographic and clinical data was collected by
structured checklists and questionnaires. Descriptive statistics were applied to describe the
results. Frequency tables and descriptive summaries were used to describe variables.
Results: Overall 22.1% of the transfusion episodes were found to be inappropriate, contributed
by various factors related to the practices, prescribers and recipients.
Conclusion: The overall prevalence of appropriate clinical utilization of blood products in this
study indicated that there is a huge gap that should be minimized; seek great attention to stablish
institutional blood transfusion committee and also guideline for appropriate clinical utilization of
blood products for the people who need them most. |
en_US |